Global Medical Imaging Reagents Market USD 19.7 Billion by 2020

The global medical imaging reagents market is estimated to reach USD 19.7 Billion in 2020, expanding at a CAGR of 8.5% from 2016 to 2020, published by iHealthcareAnalyst, Inc.

Visit the Medical Imaging Equipment Market – Product Types (Computed Tomography Scanners, Magnetic Resonance Imaging Equipment, Nuclear Imaging Equipment – PET, SPECT, Ultrasound Systems, X-Ray Devices) and Technologies (Computed Tomography Scanners, Magnetic Resonance Imaging Equipment, Nuclear Imaging Equipment – PET, SPECT, Ultrasound Systems – 2D, 3D, 4D, Doppler, High Intensity Frequency Ultrasound, Lithotripsy, X-Ray Devices – Analog, Computed, Digital Radiography) 2016-2020 report at https://www.ihealthcareanalyst.com/report/medical-imaging-equipment-market/

Medical imaging reagents are chemicals to allow clinicians to improve the imaging of specific organs, tissues, diseases and physiological functions. Medical imaging reagents are specially designed chemical compounds used to enhance images produced through imaging systems. These reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are used for diagnosing disease, monitoring disease progression, tracking therapeutic response, and enhancing our knowledge of physiology and pathophysiology. Medical imaging incorporates radiology which uses the imaging technologies of X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, endoscopy, elastography, tactile imaging, thermography, medical photography and nuclear medicine functional imaging techniques as positron emission tomography (PET) and Single-photon emission computed tomography (SPECT). Medical imaging reagents play a significant role in diagnostic, pharmaceuticals, biotechnology medical and life science industries.

The global medical imaging reagents market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global medical imaging reagents market segmentation is based on product types (contrast reagents, optical reagents, nuclear reagents), technology (fluorescent dyes and probes, fluorescent proteins, nanoparticles, quantum dots, radiopharmaceuticals), and applications (diagnostics, drug discovery and development, research and development).

The global medical imaging reagents market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global medical imaging reagents market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global medical imaging reagents market and included in this report are Bayer Healthcare AG, Bracco Imaging SpA, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, Siemens Healthcare, Thermo Fisher Scientific, Inc. and others.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/medical-imaging-equipment-market/

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.